Introduction to The Regorafenib Dose Optimization Study
Exploring The Regorafenib Dose Optimization Study reveals several interesting facts. Tanios Bekaii-Saab, MD, FACP, provides an overview of the ReDOS trial, which compared safety and efficacy with a ...
The Regorafenib Dose Optimization Study Comprehensive Overview
Tanios Bekaii-Saab, MD, and Johanna C. Bendell, MD, evaluate the ReDOS trial and explain its impact on Tanios Bekaii-Saab, MD, professor of medicine, Mayo Clinic, discusses a randomized phase II trial to evaluate Experts explore side effect management and
The panelists, John L. Marshall, MD; Tanios Bekaii-Saab, MD; Johanna Bendell, MD; Richard Kim, MD; and Charles S. Fuchs, MD ...
Summary & Highlights for The Regorafenib Dose Optimization Study
- Panelists John Marshall, MD; Alan P. Venook, MD; Johanna Bendell, MD; and Tanios Bekaii-Saab, MD, describe their clinical ...
- Tara Seery, MD, discusses Marie, a 61-year-old female from Indianapolis, Indiana, who works as a corporate IT consultant. In July ...
- John L. Marshall, MD; Mohamed E. Salem, MD; and Monica Chacha, RN, discuss overall clinical experience with treatments for ...
- Dr. Heinz-Josef Lenz discusses use and
- Panelists John L. Marshall, MD; Cathy Eng, MD; Daniel G. Haller, MD; Tara E. Seery, MD; and Tanios-Bekaii Saab, MD; outline ...
Stay tuned for more updates related to The Regorafenib Dose Optimization Study.